Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

Nature Reviews Rheumatology, Published online: 12 January 2024; doi:10.1038/s41584-023-01062-9Concerns have been raised about the safety of Janus kinase (JAK) inhibitors. This Review summarizes the evidence regarding the risks and benefits of JAK inhibitors to clarify which patients are most at risk of adverse events and guide clinical decision-making.

https://www.nature.com/articles/s41584-023-01062-9

Source: Nature Reviews Rheumatology - January 12, 2024 Category: Rheumatology Authors: Zolt án Szekanecz Maya H. Buch Christina Charles-Schoeman James Galloway George A. Karpouzas Lars Erik Kristensen Steven R. Ytterberg Attila Hamar Roy Fleischmann Source Type: research

More News: Arthritis | Rheumatoid Arthritis | Rheumatology